Bioextrax AB (publ) (STO:BIOEX)

Bioextrax AB Statistics

Total Valuation

Bioextrax AB has a market cap or net worth of SEK 112.53 million. The enterprise value is 104.61 million.

Market Cap	112.53M
Enterprise Value	104.61M

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Bioextrax AB has 46.31 million shares outstanding. The number of shares has increased by 23.35% in one year.

Current Share Class	46.31M
Shares Outstanding	46.31M
Shares Change (YoY)	+23.35%
Shares Change (QoQ)	+1.53%
Owned by Insiders (%)	17.62%
Owned by Institutions (%)	15.99%
Float	37.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	83.85
PB Ratio	8.24
P/TBV Ratio	8.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.29
EV / Sales	77.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.83

Financial Position

The company has a current ratio of 4.10

Current Ratio	4.10
Quick Ratio	3.45
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -111.91% and return on invested capital (ROIC) is -71.02%.

Return on Equity (ROE)	-111.91%
Return on Assets (ROA)	-61.55%
Return on Invested Capital (ROIC)	-71.02%
Return on Capital Employed (ROCE)	-123.63%
Weighted Average Cost of Capital (WACC)	13.80%
Revenue Per Employee	95,857
Profits Per Employee	-1.19M
Employee Count	14
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.33% in the last 52 weeks. The beta is 1.74, so Bioextrax AB's price volatility has been higher than the market average.

Beta (5Y)	1.74
52-Week Price Change	-9.33%
50-Day Moving Average	2.12
200-Day Moving Average	2.79
Relative Strength Index (RSI)	57.66
Average Volume (20 Days)	100,861

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioextrax AB had revenue of SEK 1.34 million and -16.62 million in losses. Loss per share was -0.43.

Revenue	1.34M
Gross Profit	110,000
Operating Income	-16.88M
Pretax Income	-16.62M
Net Income	-16.62M
EBITDA	-15.75M
EBIT	-16.88M
Loss Per Share	-0.43

Balance Sheet

The company has 7.92 million in cash and n/a in debt, with a net cash position of 7.92 million or 0.17 per share.

Cash & Cash Equivalents	7.92M
Total Debt	n/a
Net Cash	7.92M
Net Cash Per Share	0.17
Equity (Book Value)	13.65M
Book Value Per Share	0.34
Working Capital	7.53M

Cash Flow

In the last 12 months, operating cash flow was -14.96 million and capital expenditures -367,000, giving a free cash flow of -15.33 million.

Operating Cash Flow	-14.96M
Capital Expenditures	-367,000
Free Cash Flow	-15.33M
FCF Per Share	-0.33

Margins

Gross Margin	8.20%
Operating Margin	-1,257.60%
Pretax Margin	-1,238.60%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bioextrax AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.35%
Shareholder Yield	-23.35%
Earnings Yield	-14.77%
FCF Yield	-13.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 22, 2021. It was a forward split with a ratio of 4.

Last Split Date	Jul 22, 2021
Split Type	Forward
Split Ratio	4

Scores

Bioextrax AB has an Altman Z-Score of 27.11 and a Piotroski F-Score of 3.

Altman Z-Score	27.11
Piotroski F-Score	3